News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
191,257 Results
Type
Article (7740)
Company Profile (114)
Press Release (183403)
Multimedia
Podcasts (47)
Webinars (7)
Section
Business (58814)
Career Advice (360)
Deals (10486)
Drug Delivery (32)
Drug Development (35000)
Employer Resources (69)
FDA (3587)
Job Trends (4507)
News (106237)
Policy (7549)
Tag
Academia (340)
Accelerated approval (1)
Adcomms (2)
Allergies (30)
Alliances (14319)
ALS (36)
Alzheimer's disease (460)
Antibody-drug conjugate (ADC) (66)
Approvals (3621)
Artificial intelligence (88)
Autoimmune disease (9)
Automation (4)
Bankruptcy (68)
Best Places to Work (3554)
BIOSECURE Act (15)
Biosimilars (44)
Biotechnology (73)
Bladder cancer (24)
Brain cancer (13)
Breast cancer (79)
Cancer (812)
Cardiovascular disease (46)
Career advice (314)
Career pathing (22)
CAR-T (65)
Cell therapy (162)
Cervical cancer (7)
Clinical research (28870)
Collaboration (313)
Compensation (302)
Complete response letters (8)
COVID-19 (796)
CRISPR (9)
C-suite (115)
Cystic fibrosis (40)
Data (928)
Decentralized trials (1)
Denatured (12)
Depression (17)
Diabetes (70)
Diagnostics (1351)
Digital health (4)
Diversity (6)
Diversity, equity & inclusion (19)
Drug discovery (35)
Drug pricing (24)
Drug shortages (3)
Duchenne muscular dystrophy (23)
Earnings (25076)
Editorial (29)
Employer branding (10)
Employer resources (60)
Events (36903)
Executive appointments (333)
FDA (4032)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (233)
Gene editing (22)
Generative AI (9)
Gene therapy (91)
GLP-1 (265)
Government (828)
Grass and pollen (1)
Guidances (25)
Healthcare (2722)
Huntington's disease (10)
IgA nephropathy (9)
Immunology and inflammation (35)
Indications (13)
Infectious disease (840)
Inflammatory bowel disease (67)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (42)
Interviews (58)
IPO (5995)
IRA (14)
Job creations (1060)
Job search strategy (264)
Kidney cancer (5)
Labor market (29)
Layoffs (142)
Leadership (15)
Legal (973)
Liver cancer (26)
Lung cancer (127)
Lymphoma (65)
Machine learning (2)
Management (23)
Manufacturing (126)
MASH (49)
Medical device (910)
Medtech (911)
Mergers & acquisitions (4778)
Metabolic disorders (250)
Multiple sclerosis (37)
NASH (8)
Neurodegenerative disease (32)
Neuropsychiatric disorders (8)
Neuroscience (666)
NextGen: Class of 2025 (1079)
Non-profit (265)
Now hiring (30)
Obesity (130)
Opinion (80)
Ovarian cancer (33)
Pain (30)
Pancreatic cancer (23)
Parkinson's disease (46)
Partnered (4)
Patents (83)
Patient recruitment (46)
Peanut (15)
People (18281)
Pharmaceutical (39)
Pharmacy benefit managers (1)
Phase I (8963)
Phase II (13218)
Phase III (9561)
Pipeline (551)
Policy (75)
Postmarket research (550)
Preclinical (4199)
Press Release (29)
Prostate cancer (30)
Psychedelics (12)
Radiopharmaceuticals (116)
Rare diseases (125)
Real estate (1309)
Recruiting (29)
Regulatory (6471)
Reports (24)
Research institute (362)
Resumes & cover letters (40)
RNA editing (1)
RSV (14)
Schizophrenia (44)
Series A (42)
Series B (23)
Service/supplier (6)
Sickle cell disease (10)
Special edition (16)
Spinal muscular atrophy (48)
Sponsored (7)
Startups (1025)
State (1)
Stomach cancer (2)
Supply chain (22)
Tariffs (22)
The Weekly (34)
Vaccines (181)
Venture capitalists (17)
Weight loss (60)
Women's health (12)
Worklife (13)
Date
Today (61)
Last 7 days (299)
Last 30 days (1003)
Last 365 days (12651)
2025 (4257)
2024 (13641)
2023 (15559)
2022 (18140)
2021 (19779)
2020 (17016)
2019 (11061)
2018 (7953)
2017 (9958)
2016 (8313)
2015 (10400)
2014 (7916)
2013 (5801)
2012 (5713)
2011 (5813)
2010 (5703)
Location
Africa (181)
Alabama (19)
Arizona (36)
Arkansas (2)
Asia (14957)
Australia (1718)
California (2511)
Canada (595)
China (350)
Colorado (102)
Connecticut (97)
Delaware (80)
Europe (28418)
Florida (324)
Georgia (81)
Idaho (7)
Illinois (127)
India (8)
Indiana (91)
Iowa (6)
Japan (68)
Kansas (54)
Kentucky (8)
Maine (2)
Maryland (264)
Massachusetts (2023)
Michigan (37)
Minnesota (90)
Missouri (18)
Montana (3)
Nebraska (6)
Nevada (6)
New Hampshire (6)
New Jersey (899)
New Mexico (12)
New York (839)
North Carolina (388)
North Dakota (4)
Northern California (1188)
Ohio (78)
Oklahoma (4)
Oregon (12)
Pennsylvania (487)
Puerto Rico (8)
Rhode Island (12)
South America (227)
Southern California (968)
Tennessee (8)
Texas (253)
United States (9057)
Utah (56)
Virginia (50)
Washington D.C. (16)
Washington State (193)
Wisconsin (12)
191,257 Results for "vitro biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
May 1, 2025
·
1 min read
·
Angela Gabriel
Pharm Country
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
Matinas BioPharma Holdings, Inc. announces new in vitro data showing the use of LNCs for the delivery of small oligonucleotides was presented yesterday in a poster session at TIDES USA 2024: Oligonucleotide & Peptide Therapeutics, a hybrid in-person and virtual conference underway in Boston.
May 16, 2024
·
5 min read
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in Massachusetts impacted around 410 people, based on
BioSpace
estimates. Meanwhile, competition for jobs in those states increased year over year, according to
BioSpace
data.
April 17, 2025
·
5 min read
·
Angela Gabriel
Editorial
Biopharma Professionals Know All Too Well What Laid-Off HHS Employees Are Experiencing
Health and Human Services employees aren’t the only ones out of work. Thousands of private-sector biopharma professionals lost their jobs in the first quarter.
April 11, 2025
·
2 min read
·
Angela Gabriel
Job Trends
Getting Jobs Outside of Major Biopharma Hubs Proves Tough,
BioSpace
Finds
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, according to a
BioSpace
LinkedIn poll. Biopharma professionals in Oregon and Connecticut and a
BioSpace
recruitment manager share their insights on this issue.
February 27, 2025
·
6 min read
·
Angela Gabriel
Job Trends
Biopharma Employees’ Confidence in Employers Dips Month-Over-Month in February
Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year over year in February, according to the Glassdoor Employee Confidence Index. Glassdoor’s findings align with recent
BioSpace
data.
March 27, 2025
·
2 min read
·
Angela Gabriel
Job Trends
Settling for Less: Biopharma Professionals Taking Jobs They’re Overqualified For
Nearly half of
BioSpace
poll respondents recently took a biopharma job they were overqualified for, a finding that didn’t surprise a talent acquisition expert, who said it’s become much more likely to happen.
March 20, 2025
·
5 min read
·
Angela Gabriel
NextGen
BioSpace
’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
·
5 min read
·
Heather McKenzie
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
1 of 19,126
Next
